Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Front Oncol. 2023 Aug 25:13:1275851. doi: 10.3389/fonc.2023.1275851. eCollection 2023.

Abstract

[This corrects the article DOI: 10.3389/fonc.2023.1222716.].

Keywords: adjuvant therapy; clinicopathological features; immune markers; liquid biopsy; molecular residual disease; non-small cell lung cancer.

Publication types

  • Published Erratum